Biopharma companies turn to Skysis when they need specific and relevant expertise that is not available internally.
At all stages of the commercialization process, our team members draw on years of industry experience working across major therapeutic areas with key stakeholders in multiple healthcare channels. Our folks check their ego at the door, roll up their sleeves and work side by side with our clients to achieve their business objectives.
Public and Private Payers, PBMs, ACOs
Physician, Practice Managers, Physician Extenders, Billing Departments
Drug Distribution, Drug Retailers
Medical Societies, Pharmacy Academies
Brand, Managed Care, Medical Affairs, R&D, Corporate Communications, Legal, Regulatory
Agencies, GPOs, Specialty Pharmacies, Health Quality Organizations
Experiencing an increase in marketing activities due to product launch, annual planning or acute competitive threats? Count on Skysis’ experienced professionals and proven processes to overcome limitations in resources and expertise when you need it most.
Learn more about Skysis’ comprehensive, detailed, and fully integrated commercialization planning framework. This customized deliverable includes cost roll-up across all initiatives, with a revenue forecast to generate financial scenarios (i.e. P&L, NPV, Cash Flow, etc.) from starting point to 5 years post launch.
From early development and pivotal clinical trials to launch and lifecycle management, Skysis Market Access professionals have the insight and expertise to navigate the changing healthcare landscape and understand the most influential levers that impact product access.
We measure value based on our ability to integrate competitive insights into a client’s brand planning and corporate strategy development. Skysis Competitive Intelligence professionals have earned advanced degrees and average twenty years’ experience in the pharmaceutical industry and/or medical field. Customize your team, choosing from MDs with clinical research experience, PhDs with clinical and commercial industry experience, and PharmDs & MBAs with significant competitive intelligence experience.
Introducing “Two Thumbs Up,” a comprehensive offering from Skysis that enables biopharmaceutical professionals to confidently make the go/no-go decision relative to a drug’s commercial potential, regulatory pathway, and clinical development feasibility.
Is it time to start planning for loss of exclusivity or LOE? If your branded product faces patent expiry in the next 5 years or less, the timing is now for developing an LOE strategy. Let Skysis help you research options and design and implement a plan that minimizes generic erosion and capitalizes on specific generic opportunities.
Skysis’ Marketing Training program lets you develop brand team members and improve marketing practices, leading to stronger, more focused and results-based strategies. The program enhances consistency and drives greater collaboration and effectiveness that can lead to increased sales and optimized promotional spending.